47 studies found for:    Open Studies | "Arthritis, Psoriatic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Arthritis, Psoriatic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
Condition: Arthritis, Psoriatic
Intervention: Drug: Tofacitinib
2 Recruiting Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Conditions: Rheumatoid Arthritis;   Psoriatic Arthritis;   Ankylosing Spondylitis;   Hypertension
Interventions: Drug: Etanercept;   Drug: Adalimumab;   Drug: Certolizumab;   Drug: Infliximab
3 Unknown  TIght COntrol of Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Intensive management or Tight control;   Drug: Standard management - Control group
4 Not yet recruiting A Study of Golimumab in Participants With Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Placebo;   Drug: Golimumab
5 Recruiting Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: UCB4940 40 mg;   Drug: UCB4940 80 mg;   Drug: UCB4940 160 mg;   Drug: UCB4940 240 mg;   Drug: UCB4940 320 mg;   Drug: UCB4940 560 mg;   Other: Placebo
6 Recruiting Biologic Rheumatology Registry Across Canada
Conditions: Arthritis, Rheumatoid;   Spondylitis, Ankylosing;   Arthritis, Psoriatic
Intervention:
7 Recruiting Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis;   Crohn´s Disease;   Ulcerative Colitis;   Plaque Psoriasis
Intervention:
8 Recruiting To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis
Conditions: Psoriatic Arthritis;   Work Productivity
Intervention:
9 Recruiting 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Biological: Secukinumab;   Biological: Placebo
10 Recruiting Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Secukinumab
11 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention:
12 Recruiting Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: 210 mg brodalumab;   Drug: 140 mg brodalumab;   Drug: Placebo
13 Recruiting Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Apremilast 30 mg;   Drug: Placebo
14 Recruiting Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Condition: Psoriatic Arthritis
Interventions: Drug: Tofacitinib 5 mg BID;   Drug: Tofacitinib 10 mg BID;   Drug: Adalimumab;   Drug: Placebo
15 Recruiting Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: 210 mg brodalumab;   Drug: 140 mg brodalumab;   Drug: Placebo
16 Recruiting Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Open label H.P. Acthar Gel
17 Recruiting Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Secukinumab (AIN457);   Drug: Placebo
18 Recruiting Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Condition: Psoriatic Arthritis
Interventions: Drug: Tofacitinib;   Other: Placebo
19 Not yet recruiting Efficacy of Golimumab in Combination With Methotrexate (Mtx) Versus Mtx Monotherapy, in Improving Dactylitis, in Mtx naïve Psoriatic Arthritis Patients
Condition: Psoriatic Arthritis
Interventions: Drug: Golimumab;   Drug: Methotrexate;   Drug: Placebo
20 Recruiting Psoriatic Arthritis Treat to Target vs. Usual Care
Condition: Psoriatic Arthritis (PsA)
Intervention: Other: Intensive Care

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years